Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...

CNN’s chief international anchor Christiane Amanpour revealed on Thursday that her battle against ovarian cancer is back on ...

Investing.com -- PMV Pharmaceuticals Inc (NASDAQ:PMVP) stock rose 2.2% on Friday after the company reported encouraging clinical trial results for its cancer drug rezatapopt, showing responses across ...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) ...

Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ova ...

Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...

PMV Pharmaceuticals (PMVP) announced updated data from the Phase 2 pivotal portion of the ongoing PYNNACLE clinical trial. Results were presented ...

Christiane Amanpour is fighting ovarian cancer for a second time in a "fairly rare" form, but added that the returning cancer ...

After a month off the air, the veteran journalist disclosed that the disease had returned in what doctors described as a ...

CNN star Christiane Amanpour revealed her cancer has returned after previously beating it. “I have it again, but it’s being very well managed,” the journalist said during a Thursday, October 23, ...

Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, ...